- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 720514, 9 pages
Metabolomics Application in Maternal-Fetal Medicine
1NICU, Puericulture Institute and Neonatal Section, AOU and University of Cagliari, 09124 Cagliari, Italy
2Department of Biomedical Science, University of Cagliari, 09124 Cagliari, Italy
3Department of Woman, Mother and Neonate, Buzzi Hospital, Biomedical and Clinical Sciences School of Medicine, University of Milan, 20122 Milan, Italy
4Department of Obstetrics and Gynecology and Human Reproduction Physiopathology, University of Cagliari, 09124 Cagliari, Italy
Received 19 April 2013; Revised 10 May 2013; Accepted 13 May 2013
Academic Editor: Kaei Nasu
Copyright © 2013 Vassilios Fanos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. P. Horgan, O. H. Clancy, J. E. Myers, and P. N. Baker, “An overview of proteomic and metabolomic technologies and their application to pregnancy research,” BJOG, vol. 116, no. 2, pp. 173–181, 2009.
- P. C. Woodham, T. O’Connell, J. Grimes et al., “Metabolomics to predict severe preeclampsia in early pregnancy,” American Journal of Obstetrics and Gynecology, vol. 206, no. 1, supplement, p. S348, 2012.
- C. W. Beecher, “Metabolomic studies at the start and end of the life cycle,” Clinical Biochemistry, vol. 44, no. 7, pp. 518–519, 2011.
- W. B. Dunn, M. Brown, S. A. Worton et al., “Changes in the Metabolic Footprint of Placental Explant-Conditioned Culture Medium Identifies Metabolic Disturbances Related to Hypoxia and Pre-Eclampsia,” Placenta, vol. 30, no. 11, pp. 974–980, 2009.
- A. E. P. Heazell, M. Brown, S. A. Worton, and W. B. Dunn, “Review: the effects of oxygen on normal and pre-eclamptic placental tissue—insights from metabolomics,” Placenta, vol. 32, supplement 2, pp. S119–S124, 2011.
- M. C. Tissot van Patot, A. J. Murray, V. Beckey et al., “Human placental metabolic adaptation to chronic hypoxia, high altitude: hypoxic preconditioning,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 298, no. 1, pp. R166–R172, 2010.
- R. O. Bahado-Singh, R. Akolekar, R. Mandal et al., “Metabolomics and first-trimester prediction of early-onset preeclampsia,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 10, pp. 1840–1847, 2012.
- R. O. Bahado-Singh, R. Akolekar, R. Mandal et al., “First-trimester metabolomic detection of late-onset preeclampsia,” American Journal of Obstetrics and Gynecology, vol. 208, no. 1, pp. 58.e1–58.e7, 2013.
- E. Ferrazzi, T. Stampalija, and J. E. Aupont, “The evidence for lateonset preeclampsia as a maternogenic disease of pregnancy,” Fetal and Maternal Medicine Review, vol. 24, no. 1, pp. 18–31, 2013.
- A. E. P. Heazell, M. Brown, W. B. Dunn et al., “Analysis of the Metabolic Footprint and Tissue Metabolome of Placental Villous Explants Cultured at Different Oxygen Tensions Reveals Novel Redox Biomarkers,” Placenta, vol. 29, no. 8, pp. 691–698, 2008.
- R. P. Horgan, D. I. Broadhurst, W. B. Dunn et al., “Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies,” Placenta, vol. 31, no. 10, pp. 893–901, 2010.
- R. Antonucci, L. Atzori, L. Barberini, and V. Fanos, “Metabolomics: the “new clinical chemistry” for personalized neonatal medicine,” Minerva pediatrica, vol. 62, no. 3, supplement 1, pp. 145–148, 2010.
- T. J. Athersuch, “The role of metabolomics in characterizing the human exposome,” Bioanalysis, vol. 4, no. 18, pp. 2207–2212, 2012.
- L. Atzori, R. Antonucci, L. Barberini, J. L. Griffin, and V. Fanos, “Metabolomics: a new tool for the neonatologist,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 22, no. 3, pp. 50–53, 2009.
- L. Atzori, L. Barberini, M. L. Santoru, R. Antonucci, and V. Fanos, “Metabolomics explained to perinatologists and pediatricians,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, supplement 5, pp. 10–12, 2012.
- C. Auray-Blais, E. Raiche, R. Gagnon, M. Berthiaume, and J. C. Pasquier, “Metabolomics and preterm birth: what biomarkers in cervicovaginal secretions are predictive of high-risk pregnant women?” International Journal of Mass Spectrometry, vol. 307, no. 1–3, pp. 33–38, 2011.
- G. J. Burton, A. W. Woods, E. Jauniaux, and J. C. P. Kingdom, “Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy,” Placenta, vol. 30, no. 6, pp. 473–482, 2009.
- S. O. Diaz, J. Pinto, G. Graça et al., “Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma,” Journal of Proteome Research, vol. 10, no. 8, pp. 3732–3742, 2011.
- V. Fanos, R. Antonucci, L. Barberini, and L. Atzori, “Urinary metabolomics in the newborn and infants,” Advances in Clinical Chemistry, vol. 58, pp. 193–223, 2012.
- V. Fanos, R. Antonucci, L. Barberini, A. Noto, and L. Atzori, “Clinical application of metabolomics in neonatology,” Journal of Maternal-Fetal and Neonatal Medicine, supplement 1, pp. 104–109, 2012.
- V. Fanos, R. Antonucci, M. Zaffanello, and M. Mussap, “Neonatal drug induced nephrotoxicity: old and next generation biomarkers for early detection and management of neonatal drug-induced nephrotoxicity, with special emphasis on uNGAL and on metabolomics,” Current Medical Chemistry, vol. 19, no. 27, pp. 4595–4605, 2012.
- V. Fanos, L. Atzori, A. Dessì, E. D’Aloja, G. Finco, and G. Faa, “The kidney in post-asphyctic syndrome: state of the art,” in Developmental Nephrology: From Embryology To Metabolomics, V. Fanos, R. L. Chevalier, G. Faa, and L. Cataldi, Eds., Hygeia Press, 2011.
- V. Fanos, L. Barberini, R. Antonucci, and L. Atzori, “Metabolomics in neonatology and pediatrics,” Clinical Biochemistry, vol. 44, no. 7, pp. 452–454, 2011.
- V. Fanos, L. Barberini, R. Antonucci, and L. Atzori, “Pharma-metabolomics in Neonatology: is it a Dream or a Fact?” Current Pharmaceutical Design, vol. 18, no. 21, pp. 2996–3006, 2012.
- V. Fanos, M. Mussap, A. Noto, and L. Atzori, “Metabolomics in perinatology: where are we now?” Acta Medica Portuguesa, supplement 2, pp. 117–120, 2012.
- L. C. Kenny, D. I. Broadhurst, W. Dunn et al., “Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers,” Hypertension, vol. 56, no. 4, pp. 741–749, 2010.
- A. O. Odibo, K. R. Goetzinger, L. Odibo, et al., “First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study,” Prenatal Diagnosis, vol. 31, pp. 990–994, 2011.
- E. Turner, J. A. Brewster, N. A. B. Simpson, J. J. Walker, and J. Fisher, “Aromatic amino acid biomarkers of preeclampsia—a nuclear magnetic resonance investigation,” Hypertension in Pregnancy, vol. 27, no. 3, pp. 225–235, 2008.
- R. P. Horgan, D. I. Broadhurst, S. K. Walsh et al., “Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy,” Journal of Proteome Research, vol. 10, no. 8, pp. 3660–3673, 2011.
- G. Graça, B. J. Goodfellow, A. S. Barros et al., “UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers,” Molecular Biosystems, vol. 8, no. 4, pp. 1243–1254, 2012.
- J. Marcos, W. Y. Craig, G. E. Palomaki et al., “Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies,” Prenatal Diagnosis, vol. 29, no. 8, pp. 771–780, 2009.
- M. A. Paine, M. Scioscia, P. J. Williams, K. Gumaa, C. H. Rodeck, and T. W. Rademacher, “Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder,” Hypertension in Pregnancy, vol. 29, no. 4, pp. 375–384, 2010.
- M. Scioscia, S. Kunjara, K. Gumaa, P. McLean, C. H. Rodeck, and T. W. Rademacher, “Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus,” Diabetic Medicine, vol. 24, no. 11, pp. 1300–1304, 2007.
- A. Dessì, L. Atzori, A. Noto, V. Fanos, et al., “Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, supplement 2, pp. 35–39, 2011.
- V. Fanos, J. van den Anker, A. Noto, M. Mussap, and L. Atzori, “Metabolomics in neonatology: fact or fiction?” Seminars in Fetal & Neonatal Medicine, vol. 18, no. 1, pp. 3–12, 2013.
- A. Meloni, P. Caboni, F. Manconi et al., “Metabolomic approach to diagnosis of labour,” Abstract International Congress of Obstetrics, vol. 119, supplement 1, pp. 1–250, 2012.
- G. Graça, I. F. Duarte, A. S. Barros et al., “Impact of prenatal disorders on the metabolic profile of second trimester amniotic fluid: a nuclear magnetic resonance metabonomic study,” Journal of Proteome Research, vol. 9, no. 11, pp. 6016–6024, 2010.
- G. Graça, I. F. Duarte, A. S. Barros et al., “1H NMR based metabonomics of human amniotic fluid for the metabolic characterization of fetus malformations,” Journal of Proteome Research, vol. 8, no. 8, pp. 4144–4150, 2009.
- G. Graça, I. F. Duarte, B. J. Goodfellow et al., “Metabolite profiling of human amniotic fluid by hyphenated nuclear magnetic resonance spectroscopy,” Analytical Chemistry, vol. 80, no. 15, pp. 6085–6092, 2008.
- P. M. W. Groenen, U. F. Engelke, R. A. Wevers et al., “High-resolution 1H NMR spectroscopy of amniotic fluids from spina bifida fetuses and controls,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 112, no. 1, pp. 16–23, 2004.
- R. Romero, S. Mazaki-Tovi, E. Vaisbuch et al., “Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 23, no. 12, pp. 1344–1359, 2010.
- C. Ivorra, C. García-Vicent, F. J. Chaves, D. Monleón, J. M. Morales, and E. Lurbe, “Metabolomic profiling in blood from umbilical cords of low birth weight newborns,” Journal of Translational Medicine, vol. 10, no. 1, article 142, 2012.
- I. Tea, G. le Gall, A. Küster et al., “1H-NMR-based metabolic profiling of maternal and umbilical cord blood indicates altered materno-foetal nutrient exchange in preterm infants,” PLos One, vol. 7, no. 1, article e29947, 2012.
- D. Favretto, E. Cosmi, E. Ragazzi et al., “Cord blood metabolomic profiling in intrauterine growth restriction,” Analytical and Bioanalytical Chemistry, vol. 402, no. 3, pp. 1109–1121, 2012.
- B. H. Walsh, D. I. Broadhurst, R. Mandal et al., “The metabolomic profile of umbilical cord blood in neonatal hypoxic ischaemic encephalopathy,” PLos One, vol. 7, no. 12, article e50520, 2012.
- G. Graça, S. Diaz, J. Pinto et al., “Can biofluids Metabolic profiling help us to improve health care during pregnancy?” Spectroscopy, vol. 27, no. 5-6, pp. 515–523, 2012.